Login
Israel-Hamas Conflict
G7
World Cup
Military
War
Social Media
Benjamin Netanyahu
Artificial Intelligence
European Union
Formula 1
Drones
WWE
Aircraft
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Drug Discovery and Development image

News from Drug Discovery and Development

Information about Drug Discovery and Development

Where is Drug Discovery and Development located?Drug Discovery and Development's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Drug Discovery and Development News

RFK Jr. removes all members of CDC panel advising U.S. on vaccines
Robert F. Kennedy Jr. · United States

RFK Jr. removes all members of CDC panel advising U.S. on vaccines

43% Center coverage: 76 sources
Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he is “retiring” all 17 members of a crucial government panel of vaccine advisors. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in an opinion piece in the Wall Street Journal on Monday. See the Story
FDA Approves Merck’s Enflonsia to Prevent RSV in Infants
Merck · United States

FDA Approves Merck’s Enflonsia to Prevent RSV in Infants

51% Center coverage: 37 sources
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.The drug, Enflonsia, is a long-acting monoclonal antibody intended to prevent RSV-related lower respiratory tract disease in newborns and infants entering their first RSV season.RSV is a leading cause of hospitalization among infants in the United States, espec…See the Story
'Definite Conflicts of Interest here:' Expert Discusses New Vaccine Advisory Panel Members
Robert F. Kennedy Jr. · United States

'Definite Conflicts of Interest here:' Expert Discusses New Vaccine Advisory Panel Members

67% Center coverage: 9 sources
This week Health Secretary Robert F. Kennedy Jr. dismissed all 17 members of a CDC committee that advises the agency on vaccine safety and schedules, quickly replacing them with a panel of eight new appointees.New appointees include Dr. Robert Malone, a close Kennedy adviser who during the pandemic promoted unproven COVID-19 treatments and shared conspiracy theories about the origins of the virus.And they include epidemiologist Dr. Martin Kulldo…See the Story

The Prototype: This AI Model Could Make It Faster To Find New Medicines

67% Center coverage: 6 sources
In this week’s edition of The Prototype, we look at a new AI model that could speed up drug discovery, how the Trump/Musk blowup could impact NASA, a new class of electronics and more.CancerSee the Story

Press Release: Sanofi Accelerates Global Shipping of Beyfortus to Prepare Healthcare Providers Months Ahead of 2025-2026 RSV Season

100% Center coverage: 3 sources
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is...See the Story

Open-source Boltz-2 can speed binding-affinity predictions 1,000-fold

A team from MIT CSAIL, the Jameel Clinic, and Recursion has released Boltz-2, an open-source biomolecular model that performs physics-level protein-ligand affinity predictions in approximately 18 seconds on a single consumer GPU. This task previously required hours or days on cluster hardware, often costing upwards of $100 per molecule. By releasing the model, weights, and… The post Open-source Boltz-2 can speed binding-affinity predictions 1,00…Cambridge, Massachusetts · CambridgeSee the Story

FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades

The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.United States · United StatesSee the Story

The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives - Drug Discovery and Development

Oncology tops $84B, Mounjaro surges 124%: Your guide to the 2025 pharma landscape. FY2024 reset the competitive landscape in pharma. While oncology held its top sales standing, the rapid ascent of GLP-1s, market erosion from Humira biosimilars, and the advance of new modalities revised the new biopharma hierarchy. This deep-dive report builds on the Pharma… The post The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives appeared firs…Read Article

Dupixent Breakthrough: New Clinical Data Reveals Remarkable Success in Treating Atopic Dermatitis Across Skin Colors

First major trial reveals Dupixent's effectiveness in patients with darker skin tones. See groundbreaking results for atopic dermatitis treatment across diverse populations.See the Story

Why Microsoft Is Cautioning Businesses About Launching AI Tools

100% Center coverage: 2 sources
A company blog post says “a pretty long list” of things can go wrong with AI, so proceed carefully when integrating these tools into your daily work.Microsoft · United StatesSee the Story

Atropos Health Continues Commitment to Advancements in Oncology with Addition of Key Personnel

With growing demand for RWE in oncology for drug development and discovery and treatment, Atropos Health is adding oncology specific RWD, product features and experienced personnel to enhance experiences for clinicians and researchers PALO ALTO, Calif.–(BUSINESS WIRE)–Atropos Health, the leader in generating personalized real-world evidence (RWE) from real-world clinical data, today announced key personnel and product features enhancing their On…Palo Alto · Palo AltoSee the Story

Breaking News Topics Related to Drug Discovery and Development

Health

Health

Vaccines

Vaccines

Medical

Medical

Artificial Intelligence

Artificial Intelligence

United States

United States

News
For You
SearchBlindspotLocal